🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Giving chemotherapy before a peripheral stem cell transplant sto...
Status
Completed
Location
Multiple Locations
Start Date
2001-01
Trial ID
NCT00550784
RATIONALE: Aurora A kinase inhibitor MLN8237 may stop the growth of tumor c...
Status
Terminated
Location
Vanderbilt-Ingram Cancer Center
Start Date
2011-10
Trial ID
NCT01316692
RATIONALE: Studying proteins in head and neck cancer cells in the laborator...
Status
Completed
Location
Vanderbilt-Ingram Cancer Center - Cool Springs
Start Date
2005-05
Trial ID
NCT00896948
Retrospective cohort study for 189 couples assigned to normal and abnormal ...
Status
Completed
Location
Ganin Fertility Center
Start Date
2018-01-01
Trial ID
NCT04144621
Treatments Being Tested
RATIONALE: Diagnostic procedures, such as 3'-deoxy-3'-\[18F\] fluorothymidi...
Status
Completed
Location
Mayo Clinic
Start Date
2008-09
Trial ID
NCT00757549
RATIONALE: Lapatinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Start Date
2006-04
Trial ID
NCT00379509
RATIONALE: Drugs used in chemotherapy, such as hydroxychloroquine and temoz...
Status
Completed
Location
Abramson Cancer Center of the University of Pennsylvania
Start Date
2008-06
Trial ID
NCT00714181
Intrauterine insemination (IUI) combined with ovarian stimulation, has been...
Status
Completed
Location
Pamukkale University Faculty of Medicine, Obstetrics and Gynecology Department, Infertility Center
Start Date
2019-01-01
Trial ID
NCT04361292
Treatments Being Tested
RATIONALE: Sunitinib malate may stop the growth of tumor cells by blocking ...
Status
Terminated
Location
CCF-Fairview Hospital
Start Date
2008-10
Trial ID
NCT01118351
RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
University of Alabama, Birmingham
Start Date
2002-08
Trial ID
NCT00633750